Decoding the Weight-Loss Puzzle: How Metabolic Adaptation and Energy Utilization Shape the Future of Semaglutide Therapy
Executive Overview In the span of just a few years, medications containing semaglutide—a GLP-1 (glucagon-like peptide-1) receptor agonist initially developed to manage type 2 diabetes—have fundamentally transformed the landscape of…
